Latest Low-density lipoprotein Stories
PARIS and TARRYTOWN, New York, July 20, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that several trials within ODYSSEY, the Phase 3 clinical program of SAR236553/REGN727, have initiated patient enrollment. SAR236553/REGN727 is a potential first-in-class, subcutaneously administered, fully-human antibody that lowers low-density lipoprotein (LDL) cholesterol by targeting PCSK9 (proprotein convertase...
MADISON, N.J., July 17, 2012 /PRNewswire/ -- Raising vitamin D to optimal from deficient blood levels may not improve total cholesterol and other blood lipids, key markers of cardiovascular disease risk, according to a study published today in Circulation, a publication of the American Heart Association. The study, by researchers at Quest Diagnostics (NYSE: DGX) and The Rockefeller University, is the first large-scale examination of the clinical impact of correcting vitamin D...
BOCA RATON, Fla., July 9, 2012 /PRNewswire/ -- Seth J. Baum, MD, FACC, FAHA, FACPM, FNLA, a Boca Raton Preventive Cardiologist, cholesterol expert, and fellow of the National Lipid Association has just opened the first and only B. Braun LDL-Apheresis Center in the state of Florida. The bi-weekly LDL- Apheresis procedure can gently cleanse a patient's blood of excess cholesterol. Studies have shown that in appropriate patients the risk of heart attack and stroke can be...
(Ivanhoe Newswire) –It is known that high levels of low-density lipoprotein (LDL) cholesterol increase the risk for coronary heart disease. Now, researchers have discovered further insights about how a certain gene variant uses two mechanisms to reduce cholesterol. A variant in the human gene that encodes the protein sortilin is linked with reduced plasma LDL levels and a decreased risk of heart attack. This variant results in noticeably higher sortilin protein expression in liver. Dr....
HOFFMAN ESTATES, Ill., July 3, 2012 /PRNewswire/ -- "We believe that an individual's access to HIV testing in the privacy of their own home is critical to knowing their HIV status. It's our hope that FDA's approval of another at-home testing option will add to the body of knowledge surrounding risk factors for HIV, increase overall testing, and reduce the rates of transmission of this dangerous virus. It's important for those who choose to test at home to understand the options...
RICHMOND, Va., July 3, 2012 /PRNewswire/ -- Health Diagnostic Laboratory (HDL, Inc.) today announced that Tara Dall, MD has joined the growing advanced laboratory as Chief Medical Officer. Dr. Dall graduated in the first class of Diplomates of the American Board of Clinical Lipidology and her clinic has been nationally recognized as the first fully certified Level II lipid clinic in the United States. (Photo: http://photos.prnewswire.com/prnh/20120703/PH34547 ) "Health Diagnostic...
Recent medical research as well as new information posted at Health and Wellness portal BeWellBuzz.com, have uncovered several new key medical benefits of one of the world’s most versatile and sweet tasting natural herbs including new ways of reducing blood sugar levels for people who suffer with Type 2 Diabetes. Las Vegas, NV (PRWEB) June 21, 2012 The healing powers of the natural spice Cinnamon has been well documented in recent years. However, recent medical research as well as new...
Among individuals without known cardiovascular disease (CVD), the addition of certain apolipoproteins and lipoproteins to risk scores containing total cholesterol and high-density lipoprotein cholesterol (HDL-C) was associated with slight improvement in CVD prediction, according to a study in the June 20 issue of JAMA. "Routinely used risk prediction scores for CVD contain information on total cholesterol and HDL-C and several other conventional risk factors. There is considerable interest...
University of Minnesota Medical School researchers have collaborated with the School of Public Health and discovered an enzyme that, when found at high levels and alongside low levels of HDL (good cholesterol), can dramatically reduce the risk of cardiovascular disease. The enzyme – glutathione peroxidase, or GPx3 – is a natural antioxidant that helps protect organisms from oxidant injury and helps the body naturally repair itself. Researchers have found that patients with high levels...
PHILADELPHIA, June 10, 2012 /PRNewswire/ -- Zafgen, Inc., the world's first biopharmaceutical company dedicated to addressing the unmet need of severely obese patients, today announced new data from two Phase 1 studies of beloranib, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed significant weight loss and improvements in cardiometabolic risk markers in severely obese women. Treatment with beloranib was associated with improvements in weight loss and...
